Corrigendum to"A novel FGFR1 inhibitor CYY292 suppresses tumor progression,invasion,and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis"[Genes&Diseases 11(2024)479-494]
作者机构：School of Pharmaceutical ScienceWenzhou Medical UniversityWenzhou 325035China College of Pharmacy and Research Institute of Drug DevelopmentChonnam National UniversityGwangju 61186Republic of Korea Department of DermatologyWenzhou Hospital of Integrated Traditional Chinese and Western MedicineWenzhou 325000China Zhejiang Lab for Regenerative MedicineOujiang LaboratoryWenzhou 325035China
出 版 物：《Genes & Diseases》 (基因与疾病（英文）)
年 卷 期：2024年第11卷第3期
页 面：485-490页
核心收录：
学科分类：10[医学]
主 题：GSK3β invasion metastasis
摘 要：The authors regret that in Figure 3C,the Western Blot(WB)image representing GAPDH levels was mistakenly chosen as the same image for ERK(indicated by the red dotted-line rectangle).We have attached the original WB strip for GAPDH to demonstrate that this was an unintentional error in image ***,we noticed that the Transwell images in the two upper panels of the right column in Figure 4J are misleading due to errors in image *** have attached the original data to show that this was also an unintentional *** assure you that these two corrections do not alter the scientificconclusionof thearticle.
维普期刊数据库